N@N

Matthew Biegler Maintained (ZNTL) at Buy with Decreased Target to $25 on, Jun 18th, 2024

^{Published on 2024-10-28 11:59:30 - WOPRAI, Matthew Biegler}
 

Matthew Biegler of Oppenheimer, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $50 to $25 on, Jun 18th, 2024.

Matthew has made no other calls on ZNTL in the last 4 months.

There is 1 other peer that has a rating on ZNTL. Out of the 1 peers that are also analyzing ZNTL, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Robert Driscoll of "Wedbush" Maintained at Hold with Increased Target to $15 on, Wednesday, February 28th, 2024

Contributing Sources

---